The largest database of trusted experimental protocols

12 protocols using sodium citrate vacutainers

1

Isolation and Characterization of Human PMNs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected by venepuncture from the median cubital vein into two 5 mL sodium citrate vacutainers (Becton Dickinson). PMNs were isolated using 1-Step Polymorphs (Accurate) according to the manufacturer’s instructions. Residual erythrocytes were lysed with 1 mL of distilled water and recovered PMNs were washed in Hank’s balanced salt solution without calcium and magnesium (HBSS-/-, Gibco) and centrifuged at 1500 RCF for five minutes. The supernatant was discarded and the PMN pellet was resuspended in 1 mL phosphate buffered saline without calcium and magnesium (PBS-/-, Sigma-Aldrich). Recovered blood PMNs were quantified using a Z2 Cell and Particle Counter (Beckman Coulter) and demonstrated greater than 95% cell viability and 98% purity as assessed by a trypan blue exclusion test and Kwik-Diff staining (Thermo Fisher Scientific), respectively.
+ Open protocol
+ Expand
2

Rabbit Blood Sampling for Ex Vivo Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rabbit whole blood samples were collected in non-anticoagulated 1 mL syringes for ACT, 3.2% sodium citrate vacutainers (Becton, Dickinson. Franklin Lakes, NJ) in 3 mL volumes for cell counts, aggregometry, and 1 mL syringes containing 40 U/mL of sodium heparin (APP Pharmaceuticals, LLC Schaumburg, IL) for blood-gas analysis. Following the initiation of ECC blood flow, blood samples were collected every hour for 4 h for ex vivo measurements. Samples were used within 2 h of collection to avoid any activation of platelets, monocytes or plasma fibrinogen.
+ Open protocol
+ Expand
3

Microfluidic Platelet Adhesion Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bovine serum albumin (BSA) (A9418), 3,3’-dihexyloxacarbocyanine iodide (DiOC6) (D273), glutaraldehyde (340855) heparin salt (H3393), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (H3375), poloxamer 407 (Pluronics® F-127, P2443) were from Sigma–Aldrich (St Louis, MO, USA). 3.2% sodium citrate vacutainers (369714) and 21-gauge Vacutainer® 21 Safety-Lok blood collection sets (367281) were from Becton Dickson (Frankwood Lakes, NJ, USA). 500 µL and 100 uL glass luer lock syringes were from Hamilton (Reno, NV, USA). Tridecafluoro-1,1,2,2-tetrahydrooctyltrichlorosilane (FOTS) (SIT8174.0) was from Gelest (Morrisville, PA, USA). Polydimethylsiloxane and crosslinker were obtained from Krayden (Denver, CO, USA). Collagen related peptides (CRP-XL) [GCO(GPO)10GCOG-amide], 5(6)-carboxyfluorescein (FAM) labeled CRP-XL, GFOGER [GPC(GPP)5GFOGER(GPP)5GPC-amide], and VWF-III [GPCGPP)5GPRGQOGVMGFO(GPP)5GPC-amide] were obtained from Cambcol Laboratories (Cambridgeshire, UK). Glass slides (2” x 3“) were obtained from Fisher Scientific (Lenexa, KS, USA). Pierce Quantitative Fluorometric Peptide Assay (23290) and Texas Red dye (T20175) were from Thermo Fischer (Denver, CO, USA). Phosphate-buffered saline (PBS) was prepared to 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, and pH 7.4.
+ Open protocol
+ Expand
4

Extracellular Vesicle Isolation from Biofluids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human neuroblastoma cells, SHSY5Y, were grown in Dulbecco’s modified Eagle’s Media (Gibco, Massachusetts) supplemented with 15% fetal bovine serum (Life Technologies, California) and 1% of antibiotic-antimycotic solution (Sigma-Aldrich, Missouri) at 37 °C and 5% CO2. For EV isolation, the cells were grown in serum free media for 72 h and conditioned media was collected. Urine and blood samples were collected from consenting healthy donors. The collection and use of human samples was approved by the Regional Ethics committee. Urine samples were immediately centrifuged at 2000g for 10 min at room temperature to remove large particles and cells followed by storage at 4 °C. Human whole blood was collected in sodium citrate vacutainers (Becton Dickinson, New Jersey) and platelet-poor-plasma was obtained after two serial centrifugations at 1600g for 15 min at room temperature. The platelet-poor-plasma samples were aliquoted and kept frozen at −80 °C. For EV enrichment by acoustic trapping or ultracentrifugation, plasma samples were thawed in a 37 °C water bath for 2 min before dilution (1:1) with PBS. Prepared biological samples prior to acoustic or ultracentrifugation enrichment were defined as “Input” samples.
+ Open protocol
+ Expand
5

Platelet Function in Surgical Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Age and sex were reported at baseline. Height and weight were obtained from medical notes. BMI was derived from weight and height (kg/m 2 ). Smoking was reported as a categorical variable (0 = never smoker, 1 = ex-smoker for >5 years, 2 = ex-smoker for 1-5 years, 3 = ex-smoker for 30 days-1 year, 4 = current smoker). Platelet variables (PLT, MPV, IPF, and IPC) were measured using the Sysmex XE-2100 Automated Hematology System (Oxford, UK). Blood samples were taken pre-operatively into 3.2% sodium citrate vacutainers (BD Biosciences, Milton Keynes, UK). Platelet aggregation was measured using Multiplate multiple electrode aggregometry (MEA) (Roche, Rotkreuz, Switzerland), which detects change in electrical impedance when platelets aggregate on metal electrodes. Aggregation was determined by the area under the curve (AUC) in response to platelet agonists, including adrenaline (100 mg/mL), thrombin receptor activator peptide 6 test (TRAP-test), ADP-test, and ASPItest. Using of a combination of agonists enables evaluation of platelet activation via different pathways: adrenaline acts at the α2 adrenergic receptor, TRAP-6 acts at the protease-activated receptor-1 (PAR-1), ADP acts at the P2Y 12 receptor and arachidonic acid at the Thromboxane A2 (TxA2) receptor.
+ Open protocol
+ Expand
6

Coagulation Assay Protocol: PT and aPTT

Check if the same lab product or an alternative is used in the 5 most similar protocols
Prothrombin time (PT) and activated partial thromboplastin time (aPTT) were measured on the KC4 delta coagulometer (TCoag, Wicklow, Ireland) as previously described. 14 Briefly, arterial blood collected in 3.2% sodium citrate vacutainers (BD, North Ryde, NSW, Australia) was centrifuged at 1500 g at room temperature, and plasma stored at À80 C until analysis. PT and aPTT were determined using STA-Neoplastine Õ Cl Plus (Lot: 250461) and TriniCLOT aPTT HS reagent (Lot: G203641) (Diagnostica Stago, Donacaster, VIC, Australia). Measurements were performed in triplicate, and assays were terminated after 5 min.
+ Open protocol
+ Expand
7

Isolation of Blood Components for Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All human studies were approved by the University of Alabama at Birmingham Institutional Review Board for Human Use with all subjects providing written consent. Peripheral blood was collected from healthy volunteers by venipuncture into serum, heparin sulfate, K2EDTA, and sodium citrate vacutainers (BD Biosciences) during a single draw. Samples were kept at room temperature until blood in the serum tube was coagulated. Afterwards, samples were centrifuged at 400xg for 10 minutes to separate blood cells from serum or plasma. Samples were either directly aliquoted and stored at −80°C or given an additional round of centrifugation at 3000xg for 10 minutes to separate platelets from serum or plasma. All serum and plasma sample values depicted in figures were free of platelets. All experiments had 6 samples per group except for the experiments depicted in Figures 2 and 4.
+ Open protocol
+ Expand
8

Platelet-Poor Plasma Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood samples were collected in two 3mL sodium citrate vacutainers (BD Biosciences, India). One tube was used for ROTEM, and the second tube was used to prepare platelet-poor plasma (PPP). Plasma was separated by centrifugation at 2,000 g (3,500 rpm) for 15 min to prepare the PPP.
+ Open protocol
+ Expand
9

Coagulation Experiments with Healthy and Diseased Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected after informed, written consent as per ethical guidelines of Institutional Review Board of Partners Healthcare, Harvard Medical School and Beth Israel Deaconess Medical Center. Healthy donors: blood was collected from non-smoking healthy volunteers in a standard 6 ml no-additive blood vacutainer (BD) and 1000 U ml−1 unfractionated heparin was immediately added to a required concentration. Coagulation experiments were initiated within ∼15 min after the blood draw. For experiments where heparin concentration was <0.25 IU ml−1, blood was first drawn in 3.2% 5 ml sodium citrate vacutainers (BD) or purchased (Research Blood Components, Cambridge, MA). Patients: subjects who were taking aspirin and plavix (clopidogrel) were selected from among patients seen in the cardiac catheterization laboratory at Beth Israel Deaconess Medical Center, Boston, MA. Whole blood from patients with HPS was drawn using standard phlebotomy techniques and stored in 4.5 ml citrated (3.2% sodium citrate) tubes at room temperature. Citrated blood was used within 5 h of blood draw. The coagulation activity of these samples was restored by adding 100 μl ml−1 of 100 mM calcium chloride/75 mM magnesium chloride solution.
+ Open protocol
+ Expand
10

Platelet-Free Plasma Isolation for CLL Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected from three healthy donors (25, 32 and 45 years of age) using a 21-gauge needle. The first 3 mL of blood was discarded and approximately 8 mL was transferred within sodium citrate Vacutainers (BD Biosciences Inc.). Platelet-free plasma (PFP) was isolated within 1 hour post-collection by double centrifugation at 2,500 Â g for 15 minutes (room temperature [RT], no brake) according to the International Society on Thrombosis and Haemostasis (ISTH) guidelines. 34 Plasmas were aliquoted and stored at -80°C. Chronic lymphocytic leukaemia (CLL) plasma samples consisting of both low radioactive iodine (RAI) risk (stage 0-1) and high RAI risk (stage 3-4) were obtained from the Division of Hematology (Dr. Neil Kay) under Institutional Review Board #1827. PFPs were prepared as above and stored at -80°C until further use.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!